Aragen Biosafety Solutions (ABS), previously known as Intox Pvt Ltd, is a leading, multi-segment, multi-vertical provider of GLP-compliant nonclinical safety, toxicology, and bioanalytical services. With over 28 years of experience, ABS is an OECD GLP-certified and AAALAC-accredited organization specializing in non-clinical safety assessment.
Located on a modern, 5-acre campus in Pune, India, ABS offers comprehensive analytical, bioanalytical, and toxicological support for pharmaceuticals, biologics, medical devices, chemicals, and agrochemical products.
Its team of highly experienced professionals—including board-certified toxicologists (DABTs), pathologists (ACVP and DIBTP), study directors, veterinarians, analysts, and quality assurance experts—ensures the generation of high-quality data. To date, ABS has successfully conducted more than 19,000 GLP studies across diverse industries.
Comprehensive Scientific Solutions
Our capabilities span:
Aragen BioSafety Solutions: Trusted Global Partner in Preclinical Safety
Your Partner in Drug Development & Safety Assessment
At Aragen Biosafety Solutions, we deliver reliable safety data, regulatory expertise, and scientific excellence to help you reduce risk, accelerate development timelines, and achieve successful approvals in global markets.
Looking for a trusted partner in toxicology studies, bioanalysis, or regulatory support?
Connect with our experts to discuss your project requirements.
Aragen BioSafety Solutions is an OECD GLP-certified, AAALAC-accredited nonclinical safety and toxicology CRO with over 28 years of experience. With more than 19,000 GLP studies completed, the team includes board-certified toxicologists (DABTs), pathologists, study directors, and QA specialists — delivering end-to-end preclinical safety programs from a single, fully integrated facility in Pune, India.
Aragen BioSafety Solutions provides GLP-compliant services across three core areas: Toxicology: General, genetic, safety pharmacology, reproductive, inhalation, and carcinogenicity studies Bioanalytical & Analytical: Bioanalysis, bioassay, analytical chemistry, and clinical bioanalysis IND & Regulatory Support: Full nonclinical safety programs and dossier preparation aligned to FDA, EMA, ICH, and OECD guidelines\
Yes. Aragen BioSafety Solutions is OECD GLP-certified and AAALAC-accredited, meaning study data is accepted by the US FDA, USEPA, EMA, and other international regulatory agencies. Sponsors pursuing multi-regional approvals can rely on a single study package — eliminating the need to repeat studies for different regulatory jurisdictions.
Yes. Aragen BioSafety Solutions delivers end-to-end IND-enabling programs integrating toxicology, ADME, pharmacology, bioanalysis, and regulatory dossier support under one roof. Study designs are tailored to your molecule type — small molecule, biologic, or medical device — and aligned to FDA, EMA, and ICH requirements. Contact the team to discuss your program timeline and study design.
Yes. Intox Pvt Ltd has been rebranded as Aragen BioSafety Solutions Pvt Ltd, following its acquisition by Aragen Life Sciences. All GLP certifications, AAALAC accreditation, quality systems, scientific teams, and ongoing studies remain fully intact. Existing clients can continue their programs without any disruption, now with access to Aragen's broader integrated drug discovery and development capabilities
